Cargando…
ELAVL1 Role in Cell Fusion and Tunneling Membrane Nanotube Formations with Implication to Treat Glioma Heterogeneity
SIMPLE SUMMARY: Despite the numerous novel pharmacological and immunological approaches for multimodal glioma treatments that have been proposed in recent years, glioma phenotypic and genotypic spatial profiles in the course of treatments remain heterogeneous and, therefore, represent the biggest ch...
Autores principales: | Filippova, Natalia, Nabors, Louis B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590168/ https://www.ncbi.nlm.nih.gov/pubmed/33096700 http://dx.doi.org/10.3390/cancers12103069 |
Ejemplares similares
-
Blocking PD1/PDL1 Interactions Together with MLN4924 Therapy is a Potential Strategy for Glioma Treatment
por: Filippova, Natalia, et al.
Publicado: (2018) -
Mechanism of Membranous Tunnelling Nanotube Formation in Viral Genome Delivery
por: Peralta, Bibiana, et al.
Publicado: (2013) -
Growth Factor Dependent Regulation of Centrosome Function and Genomic Instability by HuR
por: Filippova, Natalia, et al.
Publicado: (2015) -
Effect of tolytoxin on tunneling nanotube formation and function
por: Dilsizoglu Senol, Aysegul, et al.
Publicado: (2019) -
Data on isoaspartylation of neuronal ELAVL proteins
por: Pulido, Mario A., et al.
Publicado: (2016)